# A Crossover Study to Evaluate Relative Bioavailability of Two JNJ-54781532 Tablet Formulations in Healthy Adult Participants

> **NCT02117505** · PHASE1 · COMPLETED · sponsor: **Janssen Research & Development, LLC** · enrollment: 20 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** Formulation 2
- **DRUG:** Formulation 1

## Key facts

- **NCT ID:** NCT02117505
- **Lead sponsor:** Janssen Research & Development, LLC
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-04
- **Primary completion:** 2014-06
- **Final completion:** 2014-06
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2014-06-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02117505

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02117505, "A Crossover Study to Evaluate Relative Bioavailability of Two JNJ-54781532 Tablet Formulations in Healthy Adult Participants". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT02117505. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*